X4 Pharmaceuticals Stock Quote XFOR - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

0.50

Bid

0.4988

Ask

0.50

Volume

378,861

0.49 Day's Range 0.5075

0.4721 52 Week Range 1.60

Market Cap

84.25M

Previous Close

0.486

Open

0.49

Last Trade

250

0.5

Last Trade Time

10:49:13

Financial Volume

$ 188,467

VWAP

0.497458

Average Volume (3m)

1,021,495

Shares Outstanding

168,499,514

Dividend Yield

PE Ratio

-0.83

Earnings Per Share (EPS)

-0.6

Revenue

Net Profit

-101.17M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was $0.49. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of $ 0.4721 to $ 1.60.

X4 Pharmaceuticals currently has 168,499,514 shares outstanding. The market capitalization of X4 Pharmaceuticals is $81.89 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.83.

FeaturedElement79 Gold Corp Shares Further Advances With Chachas Community on Lucero Surface Rights, Provides Corporate Update

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.02	-3.84615384615	0.52	0.5258	0.4801	997247	0.49567504	CS
4	-0.155	-23.6641221374	0.655	0.6778	0.4721	1224641	0.5347591	CS
12	-0.101	-16.8053244592	0.601	0.785	0.4721	1021495	0.61876887	CS
26	-0.69	-57.9831932773	1.19	1.25	0.4721	1903315	0.8102043	CS
52	-0.23	-31.5068493151	0.73	1.6	0.4721	2189415	0.90927599	CS
156	-3.82	-88.4259259259	4.32	6.18	0.4721	1617113	1.28674301	CS
260	-11.8	-95.9349593496	12.3	15	0.4721	1004881	1.58062704	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
HCTIHealthcare Triangle Inc	$ 1.4185 (144.99%)	105.45M
GNLNGreenlane Holdings Inc	$ 4.1401 (109.10%)	18.33M
AMIXAutonomix Medical Inc	$ 14.22 (84.44%)	13.63M
EVOKEvoke Pharma Inc	$ 9.20 (73.58%)	16.98M
RGCRegencell Bioscience Holdings Ltd	$ 7.84 (68.60%)	139.28k
SMXSMX Security Matters Public Company	$ 0.4882 (-64.88%)	7.45M
UPXIUpexi Inc	$ 5.9451 (-26.60%)	387.21k
SONNSonnet BioTherapeutics Holdings Inc	$ 4.4699 (-25.63%)	46.85k
FGIFGI Industries Ltd	$ 0.7501 (-23.20%)	856.68k
IPAImmunoPrecise Antibodies Ltd	$ 0.5327 (-21.44%)	10.06M
TWGTop Wealth Group Holding Ltd	$ 0.7263 (34.60%)	111.54M
GMMGloba Mofy AI Ltd	$ 0.4983 (41.76%)	108.97M
HCTIHealthcare Triangle Inc	$ 1.40 (141.80%)	105.43M
NVDANVIDIA Corporation	$ 141.6001 (0.04%)	57.78M
JTAIJet AI Inc	$ 0.0748 (10.16%)	51.12M